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TFIIH: a key component in multiple DNA transactions 
Jan HJ Hoeijmakers*, Jean-Marc Eglyi and Wim Vermeulen* 
The transcription factor TFllH is a versatile, multi-functional 
protein complex with multiple engagements. Apart from its 
role in basal transcription, TFllH is intimately implicated in 
DNA repair and (probably) in cell cycle control (both of 
which are required to prevent karcinogenesis) as well as 
having possible roles in other pnxesses. Thus, it is a striking 
example of the efficient use of one component for many 
purposes. Ingeniously, the incorporation of thii essential 
factor into important, but non-essential, mechanisms, such as 
DNA repair, protects against cancer. The critical role of TFllH 
in transcription function renders inactivating TFllH mutations 
lethal to cells. Without thii transcription connection, such 
mutations would lead to genetic instability and oncogenesis. 
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Introduction 
One of the basal transcription factors required for all 
structural genes is TFIIH. In recent years most of the 
nine, or more, TFIIH subunits have been either cloned 
or rediscovered. This work has disclosed unexpected 
links with other processes and has indicated a strong 
conservation of the entire complex from yeast to man 
(Table 1). Several functions have been inferred or 
demonstrated for individual TFIIH components (Table 
1). The complex is equipped with two helicases with 
opposite polarity, XPB(ERCC3) and XPD(ERCCZ), which 
were originally referred to as DNA repair factors [14]. In 
addition, at least three other TFIIH subunits are directly 
involved in repair: the yeast (in this review Sadanmyccs 
&ti) proteins Ssll and Tfbl [7’,8”] and one, as yet 
unidentified, human subunit TTDA [PO]. TFIIH also 
exhibits a kinase activity for the carboxy-terminal domain 
(CTD) of the large subunit of RNA polymerase II [lO,l l] 
due to Cdk7 (alias MOlS), a known cyclin-dependent 
kinase (CDK) activating kinase [12”,13**,14,15]. Together 
with cyclin H and Mat1 (also named p36), it forms a 
trimeric sub-complex [ 16181, that is capable of activating 
other cell cycle controlling CDK/cyclin complexes [ 19,201. 
Thus, a likely link between TFIIH and cell cycle 
regulation exists. In addition, both ~34, which harbours a 
Ssll-like zinc-finger, and ~52 have been cloned UM Egly, 
unpublished data; [21]). Because of the difficulty of iso- 
lating the intricate TFIIH complex intact, it is unknown 
whether some subunits are lost during purification and 
thus remain unidentified. 
Table 1 
Properties of doned lFNH subuntts. 
Human TFllH 
cloned gene 
XPBfERCC3 
XPD/ERCC2 
~52 
2 
Mo15ICDK7 
p34 
cydinti 
MAT1 
Yeast TFllH 
cloned gene 
SSL2iRA 025 
RALN 
TFBl 
TFB2 
SSL 1 
KIN28 
Scp94.t 
CCL1 
TFB3 
Protein properties 
3’+5’heliie 
5’+3’helicase 
7. 
WDrepeats 
2 types of Znz+-fingers 
CDK-like kinase 
Ssl 1 -like Zn%inger 
homology to cyclins 
ring Zn2+-finger 
l No known function; tyeaet cognate identified in database. 
See [l 2”,13’“]. 
TFIIH in basal transcription 
In tibv analyses have supported a model for initiation 
of basal transcription, involving an ordered assembly 
of transcription factors at the site of a promoter. This 
scenario begins with TATA-box binding by TFIID, 
followed by TFIIB and RNA polymerase II-TFIIF 
and is completed with the association of TFIIE and 
TFIIH [10,22]. Understandably, these factors (totalling 
~40 polypeptides) are operationally defined as separately 
purified components. In uitro systems have the major 
advantage, but at the same time the intrinsic limitation, 
that they simplify the complex in ufvo state. The dynamic 
chromatin conformation, which poses extra levels of 
intricacy [23], is not found in uim. Moreover, the DNA 
and protein concentrations in uioo are 100 mgml-* and 
250 mgml-1 respectively (see [24]) that is, beyond the 
point of crystallization and orders higher than what is 
found in oh. This dearth of genetic and proteinous 
material dramatically influences reaction kinetics, complex 
formation etc. More recently, evidence has emerged for 
a large RNA polymerase holoenzyme, containing most of 
the factors in a preassembled form [25,26,27*]. Such a 
‘transcription machine’ may have escaped previous detec- 
tion because of its labile structure. Although the functional 
status of these super-complexes has yet to be verified, 
the existence of highly organized DNA-metabolizing 
‘machineries’ such as this [28] is conceptually appealing. 
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All components are already on ‘standby’, circumventing 
rate-limiting diffusion of numerous factors. 
To date, TFIIH is the only known basal transcription 
factor with enzymatic activities [10,22]. The presence 
of the bidirectional helicases, XPB and XPD, implicate 
TFIIH as a ‘helix opener’ involved in the generation of 
an open initiation complex (Fig. 1). This may enable RNA 
polymerase to load onto the template-strand and promote 
formation of the first phosphodiester bonds. Such a model 
satisfies the need for ATP hydrolysis in initiation and is 
consistent with in wiho studies in which the requirement 
for TFIIH is alleviated when template melting is favoured 
[29,30’1. 
A subsequent step in the initiation reaction that may 
permit ‘promoter clearance’ [31] is the CTD phosphory- 
ration of RNA polymerase II. The CTD is composed of 
multiple heptapeptide repeats. Genetic and biochemical 
studies [32,33*,34] have identified that CTD acts as 
a target for interaction with activator proteins at the 
promoter. Its phosphorylation may disrupt this association 
and release the polymerase to allow elongation to proceed 
[35]. Although the in v,ilro transcription for some promoters 
does not depend on CTD phosphorylation [36], the CTD 
is essential in vi00 [l 11. The Cdk7Kyclin H/Mat1 trimer 
within the context of TFIIH is implicated in at least part 
of the CTD phosphorylation [37*,38]. Available evidence 
suggests that TFIIH is not involved in elongation itself 
[39], but because of the difficulty of isolating bona fide 
elongation complexes this issue has not been conclusively 
solved. 
TFIIH, DNA repair and human disorders 
The nucleotide excision repair (NER) pathway eliminates 
a wide variety of DNA lesions, including UV-induced 
pyrimidine dimers and numerous chemical adducts [40]. 
This mechanism is also highly conserved from yeast 
to man [41]. The core reaction has recently been 
reconstituted in uifro using purified components [42*,43’]. 
From the known or presumed functions of the identified 
proteins the contours of a reaction mechanism emerge 
[41,44]. The XPA protein involved in damage recognition 
recruits TFIIH, RPA and the two structure-specific 
endonucleases, XPG and the ERCCl complex, which 
cleave the damaged strand five bases downstream and 
-22 bases upstream of the injury respectively [45,46]. 
After peeling off the lesion-containing 2-7-29-mer, the 
resulting single strand gap is filled by DNA repair 
synthesis and ligation (for a review, see [41]). Evidence 
has been presented that a fraction of most yeast NER 
factors resides in a large ‘repairosome’ [47]. Thus, as with 
transcription, a preassembled ‘repair machine’ may exist. 
Obviously, DNA damage poses logistical problems for 
transcription and replication. To avoid a long interruption 
of transcription mediated by slowly removed lesions (e.g. 
pyrimidine dimers) [48], a specialized NER subpathway 
accomplishes the preferential elimination of such damage 
from the transcribed strand of active genes [49]. This 
transcription-coupled repair process involves the CSA and 
CSB products [50,51]. 
The precise role of TFIIH in NER has not yet 
been elucidated. Even so, the notion, that both NER 
endonucleases require transition from a double strand to a 
single strand region (a splayed-arm structure) for incision 
[45,46], implies that the DNA at the site of incision 
is melted. This leaves a niche for the ‘helix-opener* 
function of TFIIH (Figure 1). This model explains the 
ATP requirement of NER and is consistent with the fact 
that both TFIIH helicases are needed in the pre-incision 
stage. As in transcription, the 3’+ 5’ unwinding activity 
of XPB seems more important than the 5’ 3’ helicase 
of XPD: a complete inactivation of the XPD helicase 
function still allows partial repair and is not essential for 
transcription (G Weeda and W Vermeulen unpublished 
data). Thus, the physical integrity of XPD may be more 
important for TFIIH assembly than its functional integrity. 
In contrast, inactivation of the XPB helicase function 
completely abrogates repair and transcription, even in a 
semi-dominant fashion [52]. No clear role for the kinase 
activity of TFIIH in NER has been documented; however, 
serine/threonine phosphatase inhibitor studies suggest that 
protein phosphorylation is implicated in modulating the 
pre-incision stage (R Wood, personal communication). It 
is unknown whether the TFIIH composition is identical 
in transcription and NER. 
NER deficiencies are known to underlie the rare, genetic 
condition, xeroderma pigmentosum (XI’). This prototype 
repair syndrome is manifested predominantly as cutaneous 
symptoms: sun-sensitivity, pigmentation abnormalities and 
a > 2000-fold increased risk of skin cancer in sun-exposed 
parts of the body (Table 2), reflecting the role of NER 
in counteracting UV genotoxicity. Seven complementation 
groups (XP-A to XP-G), representing a similar number 
of genes, have been identified [41,53]. Inactivation of 
CSA and CSB, involved in transcription-coupled repair, 
result in two complementation groups of Cockayne 
syndrome (CS). This multi-systemic disease shares the 
symptom of photosensitivity with XP, and also exhibits 
severe developmental and mental impairment, including 
growth retardation and neurodysmyelination, but no skin 
cancer (Table 2) [53,54]. As it is known that individuals 
lacking XPA are totally defective in NER, including 
transcription-coupled repair, but fail to exhibit typical CS 
symptoms, it is probable that the CS products may have 
an additional non-repair function. 
The clinical spectrum associated with defects in TFIIH 
subunits is even more complex. Some TFIIH patients 
display only XP symptoms, some have combined XPKS 
symptoms and others display the photosensitive form of 
trichothiodystrophy (TTD) [PO]. The last disorder shares 
many symptoms with CS, but the definitive symptom is 
brittle hair and nails, due to a vastly reduced content of 
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Figure 1 
(a) Transcription initiation 
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Model for the role of TFIIH in transcription and repair. (a) TFIIH in initiation of basal transcription of RNA polymerase II. After binding of 
the TFIID complex to the TATA box and recruitment of TFIIB and RNA polymerase II together with TFIIF, the assembly of the initiation 
complex is completed by the association of TFIIE and TFIIH. Several proteins at the site of the promoter interact with the non-phosphorylated 
carboxy-terminal domain (CTD) of the large subunit of RNA polymerase II. The XPB-XPD bidirectional helicase duo of TFIIH is thought to 
locally open the DNA helix for loading of the RNA polymerase onto the transcribed strand and to permit synthesis of the first phosphodiester 
bonds. The CAK sub-complex of TFIIH phosphorylates the CTD, thereby disrupting the interaction of the RNA polymerase with promoter-bound 
proteins. Allowing promoter clearance and transition into elongation. (b) TFIIH in the core of the NER reaction. Lesion recognition presumably 
involving XPA is followed by the association of ss-DNA binding RPA complex and TFIIH. The ‘helix-opener’ function accomplished by the XPB 
and XPD helicases generates a locally melted region. The transition points from duplex to ss-DNA constitute substrates for the structure-specific 
endonuclease action of the ERCCl-complex and XPG which are responsible for incising the damaged strand approximately 22 bases upstream 
and 5 bases downstream of the lesion respectively. Since the helicase function of XPB appears more important for NER and transcription than 
that of XPD we favour XPB unwinding the largest part of the opened regions in transcription and repair. 
cysteine-rich matrix proteins in these structures (Table 2; 
for a review, see [55]). Mutations in at least three TFIIH 
genes are implicated in TTD: XPD (for the majority of 
patients), XPB and IlTDA (only one recorded patient) [41]. 
Analysis of XPD in XP, XP/CS and TTD patients [56-581 
is consistent with the idea that each syndrome is caused 
by different mutations in this gene. In view of the dual 
functionality of TFIIH, it is conceivable, that a mutation 
can affect either one or both the functions of XPD (Table 
3) 19,411. 
Impairment of only the NER function readily explains 
the classic XP features. Inactivation of the transcription 
function is obviously lethal as confirmed by gene targeting 
in mice (G Weeda, unpublished data). Even so, a slight 
impairment of transcription function could affect only a 
limited set of genes, which critically demand optimal 
TFIIH functioning [9,41]. It could be, for instance, that 
neurodysmyelination in CS and TTD results from a 
crippled TFIIH, affecting expression of a gene involved 
in myelination. One can envisage that a strong secondary 
structure in a promoter requires the full unwinding 
capacity (i.e. a maximally fit complex), to permit ef- 
ficient transcription. This combined ‘repair/transcription 
syndrome’ concept dissects the pleiotropic clinical features 
into those derived from a NER defect and those explained 
by a subtle transcriptional impairment. It provides a 
rationale for non-photosensitive (NER+) TTD (and CS) 
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Table 2 
Summary of maln dlnlal symptoms of TFlIH-related 
disorders. 
Clinical symptoms 
Sun-sensitivity 
Abnormal pigmentation 
Skin cancer 
Neurodysmyelination 
Bird-like facies 
Growth defect 
Hypogonadism 
Brittle hair and nails 
Scaling of skin 
XP XPICS CS l-TD 
- - 
++ 
- 
- 
+ 
+ 
+ 
+ 
+ 
+ 
* TTD and CS can patients occur without sun-sensitivity and 
NER defect. 
patients, in which only the transcription function of 
TFIIH might be affected. At the same time, it accounts 
for the extreme rarity of these syndromes, in general, and 
the relative abundance of XPD, since this gene tolerates 
even helicasc-inactivating mutations (see above). 
When the CS features in TTD are due to a basal 
transcriptional problem, this should also apply to the 
other complementation groups with CS patients (i.e. CS-A, 
CS-B and XP-G). Although the CSA, CSB (and probably 
XPG) proteins are not vital and, therefore, not essential 
for transcription, they may influence TFIIH functioning 
indirectly (Table 3). For instance, CSA and CSB could 
have an auxiliary function for TFIIH in transcription and 
in transcription-coupled (but not global genome) repair. 
The clinical picture of some XP-G (XP/CS) patients are 
more severe than XP-A patients (NGJ Jaspers, A Raams, 
unpublished data; [59]), although the latter are more 
defective in NER, suggesting that XPG has an additional 
non-repair function. Consistent with these predictions are 
the reports of interactions between the CS proteins and 
TFIIH components [4,50,60]. 
Table 3 
How can we rationalize the differences in symptoms 
between CS and TTD, such as the additional presence 
of brittle hair and nails in TTD? A significant proportion 
of TFIIH mutations in yeast yield a temperature-sensitive 
phenotype [8**,6163], probably caused by complex 
instability. It is feasible that these types of mutation 
also occur among TFIIH patients. Interestingly, two 
exceptional TTD individuals exhibited a reversible sud- 
den and dramatic worsening of hair brittleness formed 
during an episode of fever [64’,65], which is in accord 
with a human, temperature-sensitive TFIIH mutation. 
Furthermore, these phenomenon suggest it is possible 
that transcription of the genes for cysteine-rich matrix 
proteins of hair and nails is affected by TFIIH instability. 
In other cells, the steady-state levels of TFIIH may 
be sufficient because de nwo synthesis is high enough. 
The cysteine-rich matrix proteins are, however, one of 
the last gene products produced in very large quantities 
in keratinocytes before they die. Thus, the hallmark of 
TTD may be due to a TFIIH-stability problem becoming 
overt in terminally differentiated cells that are exhausted 
for TFIIH before completion of their differentiation 
program. The non-repair CS features can be explained by 
a malfunctioning of TFIIH, without concomitant complex 
instability [Table 31. Future research using CS and TTD 
mouse models should reveal whether these concepts are 
realistic. 
TFIIH and the cell cycle 
Passage through the mammalian cell cycle is controlled 
by a strict order of successive waves of activation and 
inactivation of five or more CDKs. One of these activating 
steps is the CDK phosphorylation of the threonine 
residue at position 161 within the T-loop, that controls 
access to the catalytic domain. As mentioned above, the 
TFIIH CTD kinase is the CDK-activating kinase (CAK), 
comprising the catalytic subunit Cdk7 [12**,13”], its 
regulator cyclin H and a Ring-type Znz+- finger assembly 
factor, p36 or Mat1 [16-181. The CAK trimer has been 
Model for the relrtlon betwe& TFIIH defects and dlnlal featurer’. 
TFIIH-related 
disordert NER 
TFIIH functiontt 
transcription stability 
Documented gene 
mutation 
XP + + XPD 
XPICS +/- + XPD, XPB, XPGS 
CS (photosensitive) NJ +t- + CSA, CSB 
CS (non-photosensitive)” + +I- + 7 
TTD (photosensitive) +I- +I- XPD, XPB, TTDA 
TTD (non-photosensitive)” + +/- +-I- ? 
l For further explanation see text. tFor clinical features see Table 2. ftsymbol designation: + normal function/stability, +/- partly aTfected 
function/stability, - severely impaired function. 8TFlIH transcription function may be indirectly affected by mutations in Xffi, CSA and CM. In 
addition, XPG affects total NE!?, CSA and CSB affects only transcription-coupled repair; #only the NE/? subpathway of tranacrfption-coupled 
repair is disturbed; H Recently several CS patients without a NER defect were identifti (A Reams and NGJ Jaspera, unpublffhed data). Thare 
may be disorders related to non-photosensitive variants of TTD and CS such as Netherton syndrome, Brain-Has syndrome, Pollitt syndrome, and 
similar diseases 191. 
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shown to be able to phosphorylate cell cycle CDKs [ZO] 
and its involvement in cell-cycle control is supported by 
genetic evidence in 8. cenG.&c [66’], thus, TFIIH may 
have links with cell cycle regulation as well. 
Approximately 50% of the CAK sub-complexes in a cell 
are in a free form. Both the free and TFIIH-associated 
CAK (sub)complexes are able to activate other CDKs, 
but only the TFIIH-CAK complex is capable of CTD 
phosphorylation [15] (CAK must be activated by phos- 
phorylation too). Within the set of CTD-bound proteins, 
another CDK/cyclin pair has been discovered in yeast, 
designated SRBlO and SRBll respectively [33’]. It is 
possible that CAK is a target of this kinase or vice versa 
or that they activate each other. Alternatively, they may 
work independently on the CTD and/or on CDKs. In 
contrast with the cell-cycle CDK/cyclin pairs, no cell cycle 
regulation of CAK has been observed [20]. Thus, if CAK 
has a role cell cycle control this should be consistent with 
a non-cell cycle-dependent expression profile. 
Is TFIIH involved in other processes? 
If one considers the multiple roles of TFIIH that have 
been addressed in this review, it is conceivable that this 
factor may be involved in other, as yet, unidentified 
processes. Epistatic analysis of NER mutants of TFIIH 
in yeast has failed to reveal an involvement of the 
complex in the two other major multistep repair pathways: 
recombination repair (represented by the RADSZ epistasis 
group), and post-replication repair, defined by the RAD6 
group of mutants [4O]. A caveat in these studies, which 
even applies to conditional mutants, is the fact that only 
a limited set of mutations in TFIIH subunits is viable. 
Even so, hints for additional relationships come from 
some rare r& and r&5 yeast alleles (encoding the 
XPD and XPB helicase subunits of TFIIH, respectively) 
which have increased rates of specific mutations and of 
mitotic recombination independent of the NER deficiency 
[67,68]. The available evidence suggests that Rad3 (and, 
thus, probably also Rad25, XPD and XPB) are involved 
in the stability of double strand breaks, suppressing 
homologous recombination [69@]. Interestingly, two other 
NER factors, Radl and RadlO, comprising the yeast 5’ 
incision complex, also have a dual functionality in a 
mitotic recombination pathway [70]. Thus, it is possible 
that TFIIH, together with the NER (ERCCl) Y-incision 
complex, also has a role in recombination. 
Conclusions and perspectives 
What might be the common denominator for TFIIH 
in repair, transcription and cell cycle control? One of 
the first processes registering DNA damage must be 
transcription that continuously subjects large, vital parts of 
the genome to a rigorous test for integrity. DNA damage 
triggers a cascade of events. First, overall transcription, 
even of undamaged genes, being temporarily reduced (C 
Backendorf, unpublished data). This presumably avoids 
cellular homeostasis imbalance, otherwise selectively large 
genes would suffer. Second, a cell cycle pause is induced, 
involving ~53 and numerous cell cycle checkpoint genes. 
Third, DNA repair has to be activated. TFIIH has all the 
connections and components to modulate these responses. 
The following scenario can therefore be envisaged. When 
RNA polymerase stumbles upon a lesion, TFIIH is 
recruited from the transcription into the NER mode en- 
abling repair and simultaneously shutting down transcrip- 
tion. TFIIH CAK activity may trigger cell-cycle arrest 
by its ability to regulate CDK activities. The mechanism 
controlling cell-cycle progression must be operational 
throughout the cell cycle, which fits with the constitutive 
CAK expression that is observed. When DNA damage 
is so sever that it entails a risk of oncogenesis, the 
apoptotic suicide mechanism is triggered, involving further 
accumulation of the ~53 ‘master regulator’. Local high 
concentrations of ~53, in turn, may inhibit TFIIH, thereby 
blocking repair and facilitating apoptosis. The reports 
of interactions between TFIIH subunits and ~53 are 
consistent with this idea [71]. 
The versatile application of TFIIH may be best realized 
when the transcription, repair and cell-cycle machineries 
are intimately connected. Perhaps such a connection can 
be efficiently accomplished in well organized large DNA- 
metabolizing machineries, which may be represented by 
the multi-purpose TFIIH complex. 
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